FGB Natural Products Pty Ltd is the largest fully integrated producer and manufacturer of eucalyptus oil and eucalyptus oil based products in the world. FGB’s famous heritage brand, Bosisto’s Eucalyptus, has been 'first in eucalyptus' since 1852 and remains a trusted favourite with generations of Australians.
FGB is a worldwide expert in pharmaceutical and non- pharmaceutical oils for commercial use in therapeutic, personal care, household and industrial products.
FGB is the only producer to possess a pharmaceutical manufacturing licence issued by the Therapeutic Goods Administration (TGA). This allows for the production of high quality, pharmaceutical grade oil for use in therapeutic products. All pharmaceutical grade eucalyptus oils meet the standards prescribed in the European, British and United States pharmacopoeias.
As a registered TGA manufacturer, FGB can provide the required documentation for purity and can meet all necessary specifications. Highly qualified quality control and laboratory personnel can provide accredited Certificates of Analysis
(C of A) and Material Safety Data Sheets (MSDS) as required. FGB’s TGA approved facilities comply with the Code of Good Manufacturing practice (GMP) and the Dangerous Goods (DG) Regulations applicable to the manufacture of flammable liquids.
FGB Natural Products is expert in supplying specially blended eucalyptus oils to cater for individual needs. The Company uses a range of different eucalyptus oils from
FGB harvests Blue Mallee (Eucalyptus polybractea) from extensive unique natural forest in north west Victoria. It is a sustainable, renewable resource. FGB also utilises Eucalyptus globulus, Eucalyptus citriodora (now Corymbia citriodora), Eucalyptus radiata var. australiana as well as other species
of eucalypt within its portfolio.
Eucalyptus Globulus Oil 80% min
Eucalyptus Oil Pharmaceutical BP
Eucalyptus Oil Commercial Water Soluble
Eucalyptus Oil Special Blend Water Soluble
Eucalyptus oils are comprised of more than 100 different compounds. While many of these natural compounds have their own unique attributes their effectiveness may be greatly enhanced when they combine synergistically to produce superior therapeutic or other outcomes.
Crude (single distilled) eucalyptus oils sometimes contain a greater number of compounds in different quantities than after the eucalyptus oils have been rectified (double distilled).
For instance eucalyptus globulus oil is made up of about 60% cineole and 40% many other compounds. After rectification
it contains 80% cineole and only 20% of all other compounds. This means 20% of other compounds have been siphoned
off during the second distillation. The result is the crude oil
may have a different or broader range of activities than the refined oil.
For pharmaceutical grade eucalyptus oils, they must meet the BP (British Pharmacopia) requirements and specifications. Part of the BP requirement is that the cineole (eucalyptol) content is greater than 70% for the oil to be considered pharmaceutical. FGB’s pharmaceutical grade oils all comply with the BP, USP (United States Pharmacopeia) and PH. EUR (European Pharmacopeia).
For further information click here.